Eariler: AHI Received Delisting Notification From Nasdaq For Equity Deficiency, Plans To Appeal And Address $1.15M Shortfall With Oakley Capital's $1.96M Placement And US Shelf Offering
Eariler: AHI Received Delisting Notification From Nasdaq For Equity Deficiency, Plans To Appeal And Address $1.15M Shortfall With Oakley Capital's $1.96M Placement And US Shelf Offering
Earlier: Kalibra Intentional Health Application Launched With AHI Integrated Biometric Screening
Kalibra has successfully integrated AHI's biometric scanning technology into the Kalibra platform, further extending its capability for precision health monitoring and enabling purpose-driven health.
Advanced Health Intelligence's Loss Widens in H1 FY2024
Advanced Health Intelligence's (ASX:AHI) net loss attributable to shareholders widened 98% to AU$7.7 million in the half-year ended Dec. 31, 2023, from AU$3.9 million a year earlier, according to a Th
Advanced Health Extends Master Services Agreement With Pharmak Direct
Advanced Health Intelligence (ASX:AHI) extended its master services agreement with United Arab Emirates-based Pharmak Direct by 90 days following delays caused by the former's reinstatement to the Aus
Advanced Health Intelligence Boosts Expansion Funds
UAE-based E-Script Medicine Management Company Pharmak Direct And AHI Extend Master Services Agreement
Advanced Health Intelligence Ltd (NASDAQ:AHI) ("AHI" or "the Company") is pleased to inform shareholders that the Company has extended the previously executed Master Services Agreement ("MSA") with P
Advanced Health Intelligence Grants Extension to Changlin Network to Complete Funding for Exclusive License Deal
Advanced Health Intelligence (ASX:AHI) granted Changlin Network Technology an extension to complete the funding requirements for an exclusive, perpetual license executed in August 2023. The Shanghai-b
Advanced Health Intelligence Announced Earlier It Requested An Extension To Its Voluntary Suspension Of Its Securities Pending The Release Of An Announcement In Relation To Various Potential Funding Solutions
Advanced Health Intelligence Announced Earlier It Requested An Extension To Its Voluntary Suspension Of Its Securities Pending The Release Of An Announcement In Relation To Various Potential Funding S
Advanced Health Intelligence Seeks Extension of Securities Suspension
Advanced Health Intelligence (ASX:AHI) requested an extension to its voluntary suspension of its securities pending an announcement related to various potential funding solutions. The suspension will
Trading Halt: Halted at 7:00:00 A.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:00:00 A.m. ET - Trading Halt: Halt News Pending
Advanced Health Intelligence CEO to Deliver Investor Presentation in Atlantic City
HighlightsAdvanced Health Intelligence CEO Scott Montgomery to provide a company update on traction with its digital health solutions to the investor community at the Microcap Conference in Atlantic C
Advanced Health Intelligence Partner Signs Three New Partners for UDSP Launch
Advanced Health Intelligence (ASX:AHI) said Friday that its partner Bearn signed three new partners to launch the user data sharing platform (UDSP) for the expansion of the health technology firm's re
Advanced Health Intelligence Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023
Advanced Health Intelligence (ASX:AHI) secured a AU$2.3 million tax rebate for the fiscal year ended June 30 under the Australian government's research and development tax incentive scheme. The refund
Advanced Health Intelligence Finalizes Formal Partnerships With UAE's Pharmak Direct
Advanced Health Intelligence (ASX:AHI) executed a master services agreement with Pharmak Direct, a UAE-based e-script medicine management company, according to a Wednesday release. Under the agreement
Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) ("AHI" or the "Company") would like to inform shareholders that the Company will be expanding the current biometric assessment suite with on-mo
Earlier Advanced Health Intelligence Received Deficiency Notification Letter From The Nasdaq Indicating Non-compliance With Minimum Net Shareholders' Equity Requirement Of $2.5M; Does Not Now Affect Its Securities' Listing Or Trading On Nasdaq,
Advanced Health Intelligence Ltd (NASDAQ:AHI) ("AHI" or "the Company") advises that on November 8, 2023 (Perth time), the Company received a deficiency notification letter from the Listing Qualificati
Advanced Health Intelligence to Raise AU$1 Million in Placement
Advanced Health Intelligence (ASX:AHI) is set to raise around AU$1.2 million via the placing of 10,749,996 shares priced at AU$0.11, according to a Monday report. Proceeds will be used to advance the
Advanced Health Intelligence Announced Proposed Placement of ~10.75M Shares @$0.11/Share
Advanced Health Intelligence Announced Proposed Placement of ~10.75M Shares @$0.11/Share
Advanced Health Intelligence Signs Binding Term Sheet With Electronic Medical Record and Global Personal Health Record Company OneClinic for Vietnam
HighlightsAHI signs binding term sheet with OneClinic, an electronic medical record (EMR) and personal health record (PHR) supplier for Vietnam.OneClinic holds the US Patent and Trademark Office (USPT
Advanced Health Intelligence Announced It Is Refining Its Operational Processes And Evaluating Costs; Said Optimized Its Operational Structure, Leading To An Annual Cost Reduction Exceeding A$4.8M
Advanced Health Intelligence Announced It Is Refining Its Operational Processes And Evaluating Costs; Said Optimized Its Operational Structure, Leading To An Annual Cost Reduction Exceeding A$4.8M
No Data